ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,399Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 4623

$1.64M Total Retail Price of All Prescriptions

Rank: 27 out of 4623

533 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

28% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 19,269 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 1,054 935 1 8
LEVOTHYROXINE SODIUM 874 810 2 1
POTASSIUM CHLORIDE 818 701 3 14
HYDROCODONE-ACETAMINOPHEN 705 522 S3 4 3
DONEPEZIL HCL 606 592 5 30
LISINOPRIL 487 427 6 4
OMEPRAZOLE 474 382 7 7
NAMENDA 458 438 8 36
WARFARIN SODIUM 447 387 9 24
GABAPENTIN 429 342 10 16
SIMVASTATIN 382 323 11 2
SERTRALINE HCL 333 309 12 26
AMLODIPINE BESYLATE 331 292 13 5
LANTUS 288 199 14 44
MIRTAZAPINE 281 222 15 57
CYMBALTA 278 214 16 48
METOPROLOL TARTRATE 274 250 17 9
METFORMIN HCL 243 169 18 6
CARBIDOPA-LEVODOPA 237 234 19 116
TRAMADOL HCL 221 190 20 15
PRAVASTATIN SODIUM 213 165 21 11
ALENDRONATE SODIUM 207 205 22 22
CLOPIDOGREL 205 184 23 31
FLUTICASONE PROPIONATE 202 171 24 32
TAMSULOSIN HCL 198 170 25 29
RISPERIDONE 197 174 26 72
NOVOLOG 197 129 26 123
HYDROCHLOROTHIAZIDE 183 168 28 10
CITALOPRAM HBR 183 146 28 23
KLOR-CON M20 182 160 30 102
QUETIAPINE FUMARATE 181 169 31 74
ZOLPIDEM TARTRATE 180 140 32 18
OLANZAPINE 179 115 33 127
METOPROLOL SUCCINATE 172 123 34 13
ABILIFY 168 128 35 161
ESCITALOPRAM OXALATE 168 149 35 75
SINGULAIR 165 143 37 83
ALLOPURINOL 162 115 38 37
PANTOPRAZOLE SODIUM 153 129 39 35
FENTANYL 149 134 S2 40 118
RAMIPRIL 148 148 41 76
PLAVIX 146 135 42 45
PAROXETINE HCL 144 127 43 78
ATORVASTATIN CALCIUM 130 103 44 12
NEXIUM 129 117 45 17
NOVOLIN R 127 106 46 113
PREDNISONE 127 117 46 50
BACLOFEN 125 47 48 133
TIZANIDINE HCL 122 72 49 111
FAMOTIDINE 119 110 50 82
KLOR-CON M10 117 111 51 137
RANITIDINE HCL 116 109 52 47
ATENOLOL 114 89 53 28
DIOVAN 110 87 54 39
LYRICA 107 63 55 66
NIASPAN 105 48 56 110
SULFAMETHOXAZOLE-TRIMETHOPRIM 105 89 56 68
LACTULOSE 103 68 58 106
DIGOXIN 102 101 59 58
CARVEDILOL 101 101 60 25
MONTELUKAST SODIUM 100 79 61 158
AZITHROMYCIN 100 86 61 33
BUSPIRONE HCL 99 70 63 135
METOCLOPRAMIDE HCL 98 54 64 126
NYSTATIN 97 78 65 175
CEFTRIAXONE 97 75 65 262
ADVAIR DISKUS 95 60 67 62
LEVETIRACETAM 95 64 67 114
DIVALPROEX SODIUM ER 92 70 69 148
CRESTOR 90 63 70 20
CELEBREX 88 76 71 89
LEVOFLOXACIN 88 84 71 81
DIVALPROEX SODIUM 86 77 73 90
CIPROFLOXACIN HCL 86 76 73 43
ROPINIROLE HCL 84 67 75 108
GLYBURIDE 83 59 R 76 59
ALBUTEROL SULFATE 83 63 76 142
IPRATROPIUM-ALBUTEROL 81 70 78 177
LIDOCAINE HCL 79 63 79 271
HALOPERIDOL 79 52 79 214
OXYBUTYNIN CHLORIDE 76 50 81 120
OXYBUTYNIN CHLORIDE ER 75 34 82 163
PROMETHAZINE HCL 74 56 R 83 93
MELOXICAM 74 47 83 27
AMIODARONE HCL 74 73 83 207
SEROQUEL 71 68 86 149
EVISTA 69 69 87 128
LOSARTAN POTASSIUM 68 55 88 21
FENOFIBRATE 67 65 89 54
JANUVIA 67 58 89 52
SPIRONOLACTONE 66 45 91 77
POLYETHYLENE GLYCOL 3350 64 57 92 91
CYCLOBENZAPRINE HCL 64 37 R 92 53
ISOSORBIDE MONONITRATE ER 64 58 92 60
TRIMETHOPRIM 64 52 92 421
AMOX TR-POTASSIUM CLAVULANATE 63 46 96 117
FINASTERIDE 63 63 96 109
NITROFURANTOIN MONO-MACRO 62 40 98 172
LATANOPROST 62 62 98 224
NITROFURANTOIN 61 57 100 243
VENLAFAXINE HCL 61 51 100 279
BENZTROPINE MESYLATE 60 24 R 102 141
SPIRIVA 60 50 102 79
LEVEMIR 59 55 104 154
GEMFIBROZIL 58 30 105 94
METOLAZONE 58 43 105 208
SUCRALFATE 58 42 105 183
PROAIR HFA 58 37 105 64
FLUCONAZOLE 57 44 109 189
LEXAPRO 57 47 109 220
CLONIDINE 57 26 109 264
ZAFIRLUKAST 56 41 112 530
DOXYCYCLINE HYCLATE 56 49 112 101
TRIAMCINOLONE ACETONIDE 55 51 114 124
CLONIDINE HCL 54 34 115 40
PHENYTOIN SODIUM EXTENDED 53 27 116 119
NIFEDIPINE ER 51 47 117 97
MECLIZINE HCL 51 25 117 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.